WealthStone’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
WealthStone's ELV Position: Q1 2021 in Review
WealthStone increased its Elevance Health (ELV) stake by 6.4% in Q1 2021, buying an estimated $19.3K and bringing the position to 1,003 shares worth $360K. The position accounts for 0.13% of the portfolio, ranked #124.
WealthStone first reported a position in ELV in Q2 2019 and has held it in 4 quarters since. 1,211 funds tracked by Wall St. Rank hold ELV as of Q1 2021.
- WealthStone held 1,003 shares of Elevance Health worth $360K as of Q1 2021.
- WealthStone bought 60 Elevance Health shares in Q1 2021, an estimated $19.3K.
- Elevance Health made up 0.13% of WealthStone's portfolio in Q1 2021, its #124 holding.
- WealthStone first reported a position in Elevance Health in Q2 2019 and has held it in 4 quarters since.
- 1,211 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.
Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.